Ceacam6 (carcinoembryonic antigen-related cell adhesion molecule 6 gene) has recently been isolated by differential display followed by RT-PCR and DNA sequence analyses. Ceacam6 is a member of an immunoglobulin superfamily and encodes a protein of 266 amino acid residues possessing one immunoglobulin (Ig)-like domain. RT-PCR analysis showed that Ceacam6 was dominantly expressed in rat testis and its expression level prominently increased after 6 wk of postnatal development in testis. Immunohistochemical analyses using the anti-CEACAM6 antibody revealed that CEACAM6 colocalized with intermediate filaments (vimentin) in Sertoli cells and interstitial cells. The association between CEACAM6 and vimentin was observed throughout postnatal development in rat testis. Transfection experiments performed in COS-7 cells suggested that overexpression of CEACAM6 brought about aggregation of vimentin filament around nuclei with which CEACAM6 colocalized and that the N-terminus region of CEACAM6, including the Ig-like domain, seemed to be required for association with vimentin filaments. Interaction between CEACAM6 and vimentin in rat testis and transfected COS-7 cells was confirmed by immunoprecipitation. Our observations strongly suggested that CEACAM6 might be a novel intermediate filament-associated protein involved in regulation of vimentin architecture in Sertoli cells.
INTRODUCTION
Germ cell development is a highly complicated and regulated process that is divided into three phases: 1) mitotic proliferation of diploid spermatogonial stem cells; 2) meiosis, which gives rise to haploid round spermatids; and 3) metamorphosis of haploid round spermatids (defined as spermiogenesis). During spermiogenesis, round spermatids undergo extensive morphological changes, including formation of an acrosome and a flagellum, condensation of the nucleus, and elimination of residual cytoplasm [1, 2] , through which round spermatids differentiate into mature spermatozoa. This highly regulated process needs appropriate structural and functional support by Sertoli cells that exhibit drastic changes in cell shape and internal cytoskeletal organization in concert with seminiferous epithelium cycles [3] .
The cytoskeleton in eukaryotic cells comprises three major fibrous polymers: microfilaments, microtubules, and intermediate filaments (IFs) [3, 4] . IFs function as the resilient components and cytoskeletal scaffolds in the nucleus and the cytoplasm. IF proteins are subdivided into six different types on the basis of sequence homology: 1) type I keratins, 2) type II keratins, 3) vimentin-related proteins, 4) neurofilament proteins, 5) lamins, and 6) lens-specific proteins [5, 6] . Sertoli cells of the seminiferous epithelium possess IFs composed predominantly of the vimentin-type filaments [7] that are formed by polymerization of 57-kDa vimentin monomers. In cells in general, it has been suggested that vimentin IFs are significantly concerned in cytoskeletal organization and cell morphology [8] . Vimentin filaments in the Sertoli cell encircle the nucleus and extend toward the cell periphery where the junctions between the Sertoli cells and spermatids are formed [9] . The distribution of vimentin filaments in adult rat Sertoli cells shows periodical changes in coordination with seminiferous epithelium cycle [3] , but how the dynamics of vimentin filaments are accurately controlled in the cells remains unknown. Identification and characterization of vimentin-associated proteins in Sertoli cells seems to be essential for understanding the molecular mechanism for vimentin dynamics.
We have recently isolated carcinoembryonic antigen-related cell adhesion molecule 6 (Ceacam6) and its novel spliced variant Ceacam6-Long (Ceacam6-L) from rat testis by differential display and cDNA cloning technique [10] . Ceacam6-L, produced by retention of 67-nucleotide-long third intron in Ceacam6 gene, is a member of an immunoglobulin (Ig) superfamily and encodes a protein of approximately 50 kDa with an Ig-like domain, three IgCAM domains, a transmembrane region, and a short intracellular domain. We found that CEACAM6-L localized to the interface between Sertoli cells and germ cells [10] in the region where apical ectoplasmic specializations (EPSs) form [11] . Apical EPSs are responsible for anchoring spermatids to Sertoli cells and sperm release into the lumen of the seminiferous epithelium (spermiation). CEACAM6-L might be involved in spermatogenesis as an adhesion molecule at the apical EPSs in testis.
In this study, we report that CEACAM6 with one Ig-like protein colocalized with vimentin filaments in Sertoli cells and interstitial cells in rat testis. In transfected COS-7 cells, FLAGtagged CEACAM6 expressed in the cells tended to associate with intrinsic vimentin filament, and its overexpression brought about aggregation of vimentin filament around nuclei.
MATERIALS AND METHODS

Animals
Animal experiments were approved by the animal experimental committee of Kyushu University. Investigations were conducted in accordance with the National Research Council publication Guide for Care and Use of Laboratory RNA Isolation, cDNA Synthesis, and RT-PCR Total RNAs were isolated from testis, epididymis, lung, kidney, intestine, stomach, brain, heart, liver, skeletal muscle, and spleen of 8-wk-old ether-or isoflurane-anesthetized Wistar male rats by QuickPrep Total RNA Extraction Kit (GE Health BioScience Corp.). Total RNA was also isolated from testis of 1-to 8-wk-old rats. cDNA strands were synthesized from 3 lg of total RNA by using a PrimeScript 1st strand cDNA Synthesis Kit (TAKARA Biotech Co.) with oligo-(dT) primer. The reverse-transcribed cDNA was used as a PCR template to synthesize a gene. PCR was performed using LA Taq DNA polymerase (TAKARA Biotech). The primers used to amplify an open reading frame of full-length Ceacam6 were 5 0 -ATG GAG CCC CCC TCA GCC CAT C-3 0 (forward) and 5 0 -ACT TAT GCT GAC CTG GTG GAT AGA C-3 0 (reverse). Primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 5 0 -TGA AGG TCG GTG TCA ACG GAT TTG GC-3 0 (forward) and 5 0 -CAT GTA GGC CAT GAG GTC CAC CAC-3 0 (reverse). The PCR-amplified DNA was cloned into pGEM-T easy vector (Promega) and sequenced using a DNA sequencer (Applied Biosystems).
Antibody Production
The antibody against CEACAM6 was produced in rabbit against the amino acid sequence NH 3 -RTNTLRKAGAC-COOH of CEACAM6 (Fig. 1) . The synthetic peptide was coupled to keyhole limpet hemocyanin (KLH; Sigma, St. Louis, MO), and the peptide coupled to KLH (1 mg total dose) was dissolved in 1 ml of saline, emulsified with 1 ml of Freunds complete adjuvant, and injected at multiple sites on the back of a rabbit as described previously [12, 13] . The antiserum was collected within 2 wk after the third injection. Affinity purification of the antibody was carried out over a matrix of the peptide coupled to formyl-cellulofine (Seikagaku Kohgyo) as described previously [12, 13] . Adsorbed antibody was made by incubation of the affinity-purified antibody (2 ll) with the synthetic peptide (1 mg) for 12 h at 48C and centrifuged for 30 min at 15 000 rpm, and the resultant supernatant was collected as an adsorbed antibody.
Preparation of Glutathione S-Transferase-Fusion Proteins
Rat Ceacam6 mRNA has an open reading frame of 798 nucleotides encoding 266 amino acids. Whole-length amino acids of CEACAM6 was PCRamplified using the primer 5 0 -GCT GAA TTC ATG GAG CCC CCC TCA GCC CAT C-3 0 (forward) and the primer 5 0 -AAT GAA TTC TGC TGA CCT GGT GGA TAG ACA GC-3 0 (reverse). Amplified PCR products were digested by EcoRI and cloned in frame to the COOH terminus of glutathione Stransferase (GST) using the pGEX-4T-1 system (GE Healthcare BioScience Corp.). Recombinant proteins were expressed in Escherichia coli and purified onto glutathione-sepharose (GE Healthcare BioScience) as previously described [14, 15] . The molecular size of GST-CEACAM6 is approximately 55 kDa. GST-fused recombinant proteins, CEACAM6-L, syntaxin 2, RAB3A, MRF, SPATA21 (spergen 3), and spetex2 were similarly produced and purified. These recombinant proteins were used for immunoblot analysis.
Immunoblot Analysis
Testes of ether-anesthetized adult Wistar rats were immersed in PBS on ice, and the capsule (tunica albuginea) was torn away with tweezers. Seminiferous tubules released from testes were untangled and washed several times in PBS at 48C with gentle agitation to remove interstitial cells. Removed interstitial cells were collected by centrifugation. Both seminiferous tubules and interstitial cells were dissolved in RIPA buffer (50 mM Tris [pH 7.2], 1 mM EDTA, 0.1% SDS, 0.1% Na deoxycholate, 1% Nonidet P-40, protease inhibitors cocktail [Roche Diagnostics]), followed by centrifugation at 15 000 rpm for 20 min. Clarified supernatants were used as samples for SDS-PAGE and immunoblot analysis. The sample proteins prepared for SDS-PAGE were separated on 12% acrylamide gel, and separated proteins were either stained with Coomassie brilliant blue or transferred to Hybond-P (PVDF; GE Healthcare BioScience Corp.) membranes. The membranes were incubated for 3 h with the affinitypurified anti-CEACAM6 antibody diluted 1:5000 with a blocking buffer (PBS containing 5% nonfat milk and 0.05% Tween-20), followed by incubation with HRP-conjugated goat anti-rabbit IgG (BioRad) in the same buffer. Antigenantibody complexes were visualized using an ECL-Plus detection kit (GE Healthcare BioScience). GST-fused proteins were similarly processed for immunoblot analysis.
Immunohistochemistry
Postnatal Day 7, 14, 21, and 28 and adult rat testes were fixed in 4% paraformaldehyde in PBS at 48C for 4 h, washed three times in PBS, incubated in PBS containing 50 mM NH 4 Cl for 30 min, and then rinsed in PBS. After infiltration of 20% (w/v) sucrose in PBS, the testes were immersed in OCT compound (Tissue-Tek; Miles Inc.) and immediately frozen by liquid nitrogen. Frozen sections of 10-lm thickness were cut by a cryostat (CM1850; Leica). The sections were attached to poly-L-lysine-coated glass slides. The sections were washed in PBS, exposed to 0.1% Triton X-100 in PBS, and then either immunostained for 2 h by the anti-CEACAM6 antibody diluted 1:500 with a blocking buffer (PBS containing 5% nonfat milk) or double immunostained by the polyclonal anti-CEACAM6 antibody and the monoclonal anti-tyrosine tubulin antibody (T9028; Sigma) diluted 1:500 and 1:1600 with the same buffer, respectively, followed by incubation for 1 h with goat anti-rabbit IgG conjugated with fluorescein isothiocyanate (FITC; GE Healthcare BioScience) and anti-mouse IgG conjugated with Cy3 (GE Healthcare BioScience Corp.). Some of the samples were double immunostained with the anti-CEACAM6 antibody and monoclonal anti-vimentin antibody (V 6630; Sigma) diluted 1:500 and 1:200, respectively, followed by incubation with goat anti-rabbit IgG conjugated with FITC and anti-mouse IgG conjugated with Cy3. For nuclear staining, immunostained samples were incubated for 30 min with PBS containing SYTOX Orange (1:10 000 dilution; Molecular Probes) or Hoechst 33342 (Sigma). The samples were washed with PBS and examined either by a confocal laser scanning microscope (Nikon A1) or by a fluorescent microscope (Leika DMRXA). For controls, the primary antibody was replaced by preimmune serum or the anti-CEACAM6 antibody adsorbed with the synthetic peptide (adsorbed antibody) as described above.
To observe the distribution of CEACAM6 in rat Sertoli cells during postnatal development, the sections of Postnatal Day 7-28 testes were immunostained using the anti-CEACAM6 antibody and either monoclonal anti-vimentin antibody or monoclonal anti-GATA4 antibody (1:200 dilution, sc-25310; Santa Cruz Biotechnology), as described above. GATA4 is a transcription factor highly expressed in Sertoli cells in testis. 
INVOLVEMENT OF CEACAM6 IN VIMENTIN ARCHITECTURE
Transfection of CEACAM6
A full-length open reading frame of CEACAM6 was PCR-amplified using the primer 5 0 -AGC GAA TTC AAC CAT GGA GCC CCC CTC AGC CCA TC-3 0 (forward) and the primer 5 0 -AGT GAA TTC GCT GCT GAC CTG GTG GAT AGA CAG C-3 0 (reverse). Primers for Ceacam6 lacking the C-terminal 118 amino acids were 5 0 -AGC GAA TTC AAC CAT GGA GCC CCC CTC AGC CCA TC-3 0 (forward) and 5 0 -AGT GAA TTC CTT CGT ATG GTG GGC TTG CTT AAC-3 0 (reverse). Primers for Ceacam6 lacking the Nterminal 144 amino acids were 5 0 -AGC GAA TTC AAT GCC CAC CAT ACG AAG CAA CAG G-3 0 (forward) and 5 0 -AGT GAA TTC GCT GCT GAC CTG GTG GAT AGA CAG C-3 0 (reverse). Amplified PCR products were digested by EcoRI and cloned in frame to pFLAG-CMV-5.1 expression vector (Sigma). Plasmid DNAs were transfected into COS-7 cells using LIPOFECTAMINE-LTX reagent (Invitrogen) following the manufacturer's instruction. After 48 h of culture, transfected cells were fixed with 3% paraformaldehyde in PBS for 15 min, treated with 50 mM NH 4 Cl for 10 min, permeabilized in 0.1% Triton X-100 for 5 min, and washed by PBS. After exposure to PBS containing 5% nonfat milk, transfected cells were double immunostained by polyclonal anti-DDDDK-Tag antibody (MBL) diluted 1:5000 and monoclonal anti-vimentin antibody diluted 1:200 in the blocking buffer, followed by incubation with Cy3-conjugated with goat anti-rabbit IgG (Amersham Pharmacia Biotech) and anti-mouse IgG conjugated with FITC. To stain nuclei of COS-7 cells, immunostained cells were exposed for 30 min to PBS containing Hoechst 33342. The samples were washed with PBS and examined either by the confocal laser scanning microscope or by the fluorescence microscope.
Preparation of Cytoskeleton-Enriched Fraction and Immunoprecipitation
Seminiferous tubules released from testes were untangled and washed several times in PBS at 48C with gentle agitation to remove interstitial cells. Seminiferous tubules were dissolved in cytoskeleton extraction buffer (0.15 M NaCl, 100 mM HEPES [Katayama Chemical], 60 mM PIPES [Sigma], 1.0% Triton X-100, protein inhibitors cocktail), followed by centrifugation at 10 000 rpm for 10 min. The pellet was solubilized with RIPA buffer, followed by centrifugation at 15 000 rpm for 20 min. Clarified supernatants were used as samples for immunoprecipitation with monoclonal anti-vimentin antibody as described previously [16] . Immunoprecipitated proteins were separated by SDS-PAGE and processed for immunoblot analysis using either anti-vimentin antibody or anti-CEACAM6 antibody, followed by incubation with HRP conjugated protein-G (BioRad).
COS-7 cells transfected with pFLAG-CMV-5.1 expression vector were harvested after 48 h of culture and solubilized in RIPA buffer for 30 min at 48C, and the supernatants obtained by centrifugation for 20 min at 10 000 rpm was used for immunoprecipitation with monoclonal anti-FLAG antibody (Sigma). Immunoprecipitated proteins were processed for immunoblot analysis using either anti-FLAG antibody or anti-vimentin antibody, followed by incubation with goat anti-mouse IgG conjugated with-HRP (BioRad). Nontransfected COS-7 cells were used for immunoblot as a control.
RESULTS
Expression Analysis
We performed RT-PCR to examine both the expression of Ceacam6 in various organs of adult rats and the developmental expression of Ceacam6 in rat testes. Primers were design to amplify an open reading frame (798 bases) of full-length Ceacam6 (Fig. 1) . As shown in Figure 2 , the expression level of Ceacam6 in testis was much higher than that in other organs. PCR products were faintly detectable until 5 wk of postnatal development of testis, and its expression level rapidly increased thereafter. 
Immunoblot Analyses of CEACAM6
To examine the expression and the localization of CEACAM6 protein (accession no. BC078962) in rat testis, a polyclonal antibody was raised against the synthetic peptide (RTNTLRKA-GAC) corresponding to amino acid residues 221-231 of CEACAM6 (Fig. 1) . Although the N-terminal half of the sequence is shared by CEACAM6 and its variant CEACAM6-L, the sequence of the peptide is specific for CEACAM6, not found in CEACAM6-L. The anti-CEACAM6 antibody was used after affinity purification. Specificity of the affinity-purified anti-CEACAM6 antibody was first examined on the blot to which several GST-fused recombinant proteins were transferred. As shown in Figure 3A , the anti-CEACAM6 antibody specifically recognized GST-CEACAM6 but did not react with other GSTfusion proteins, including GST-CEACAM6-L, indicating that the antibody is specific for CEACAM6. 
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To detect the CEACAM6 protein biochemically in testis, we performed immunoblot analysis on the blots to which proteins extracted from rat seminiferous epithelium (SE) and interstitial cells (IC) were transferred (Fig. 3B , SE: lane 1, IC: lane 2). On the blot, the anti-CEACAM6 antibody recognized a band migrating at approximately 36 kDa (lane 1) and 27 kDa (lane 2) in the SE and IC, respectively. The size of the protein detected in the IC sample (27 kDa) was close to the molecular weight of full-length of CEACAM6 (29.5 kDa) calculated from the CEACAM6 amino acid sequence deduced from the cDNA sequence, while the size of the protein detected in the SE sample (36 kDa) was larger than its predicted molecular weight. The reason for this apparent difference is not clear at present. CEACAM6 protein was undetectable in the sample prepared from purified spermatozoa (not shown).
Immunolocalization of CEACAM6 in Testis
To localize CEACAM6 within the testis, sections of rat testis were processed for immunohistochemistry with the anti-CEACAM6 antibody. Immunoreactive products for CEA-CAM6 were detected in the cells residing on the basement membrane of the SE as well as in the IC (Fig. 4A) . At high magnification of the SE (Fig. 4B) , the immunosignal for CEACAM6 was found in Sertoli cell perinuclear cytoplasm with filamentous staining extending toward the cell periphery (Fig. 4B, arrow) . When the sections were double labeled by the anti-CEACAM6 antibody and the anti-tyrosine tubulin antibody that specifically marks Sertoli cells, the cells with CEACAM6 immunosignal were found to be immunopositive for Tyrosine tubulin (Fig. 4C) , which is consistent with our conclusion that the cells expressing CEACAM6 are Sertoli cells. Control sections stained with preimmune serum or adsorbed anti-CEACAM6 antibody did not produce any specific immunolabeling in the testis (Fig. 4D) .
The immunolabeling pattern of CEACAM6 in Sertoli cells (Fig. 4B) 
INVOLVEMENT OF CEACAM6 IN VIMENTIN ARCHITECTURE
concert with the seminiferous tubule cycle, we examined CEACAM6-vimentin association in a variety of stages of the seminiferous tubules.
In the SE of stages I-III, CEACAM6 was found to be colocalized with immunolabeled vimentin that developed around nuclei and extended as the cytoplasmic filaments toward the periphery of Sertoli cells (Fig. 4E) . Interstitial cells between seminiferous tubules were also positive for CEA-CAM6 and vimentin (Fig. 4, E-G, arrowheads) . At stages IV-V, the cytoplasmic filaments of CEACAM6 in Sertoli cells were distinct (Fig. 4F, arrow) . CEACAM6 immunosignal, as well as vimentin immunosignal at stages VII-VIII, was remarkably weaker than that in other stages, often hardly detectable in the cytoplasm of Sertoli cells (Fig. 4G) . Throughout all stages of the seminiferous cycles (including stages IX-XIV, data not shown), immunolabeled CEACAM6 was colocalized with vimentin. These observations suggested that CEACAM6 expressed in Sertoli cells and that IC was associated with vimentin filaments at all stages.
Distribution of CEACAM6 in Rat Sertoli Cells During Postnatal Development
To examine the distribution of CEACAM6 in rat Sertoli cells during postnatal development, frozen sections of Postnatal Day 7, 14, 21, and 28 testes were processed for immunohistochemistry with the anti-CEACAM6 antibody. Since immunoreactive products for CEACAM6 were colocalized with intermediate filaments in Sertoli cells (Fig. 4) , the antibody against GATA-4, a marker for Sertoli cell nuclei, was used in combination with the anti-CEACAM6 antibody.
At Postnatal Day 7, immunostained CEACAM6 was located mainly at the basal region of Sertoli cells on the basement membrane of the SE, and CEACAM6-positive cytoplasmic filaments were rarely observed (Fig. 5A) . At Postnatal Day 14, the nuclei of Sertoli cells, which were elongated and migrated from the basal toward the central region of seminiferous tubules, were connected to the basement membrane by ''foot'' structures with CEACAM6 immunosignal (Fig. 5B, inset) . At this stage, germ cells tended to locate at the most outside the SE. At Postnatal Day 21, at which time germ cells rapidly increased in number within the SE, the CEACAM6-positive foot structures were still clearly observed between germ cell nuclei (Fig. 5C, inset) . At Postnatal Day 28, both CEACAM6-positive filaments developed around nuclei, and the foot structures of Sertoli cells were recognized (Fig. 5D) .
We next examined the positional relationship between CEACAM6 and intermediate filaments in Sertoli cells during postnatal development by using the antibodies against vimentin and CEACAM6. The results showed that immunolabeled CEACAM6 was colocalized with vimentin throughout Postnatal Days 7-28 ( Figure 6 , B-D, the vimentin-and CEACAM6-positive foot structures of Sertoli cells were seen between germ cell nuclei (arrowheads).
Interaction Between CEACAM6 and Vimentin in Rat Testis
To confirm the interaction between CEACAM6 and vimentin in testis, seminiferous tubules were dissolved in a cytoskeleton extraction buffer. After centrifugation, insoluble cytoskeleton-enriched fractions were lysed in RIPA buffer and processed for immunoprecipitation with the anti-vimentin antibody. Precipitated proteins were subjected to immunoblot analysis using either the anti-vimentin antibody (Fig. 7A) or the anti-CEACAM6 antibody (Fig. 7B) . On the blot, the antivimentin antibody recognized vimentin proteins migrating at 50 kDa overlapped with heavy-chain polypeptide of IgG (Fig.  7A) . CEACAM6 was detected in the immunoprecipitates but was undetectable in the samples immunoprecipitated by preimmune serum (Fig. 7B) . The result suggested that CEACAM6 directly interacted with vimentin in the seminiferous tubules.
Effects of CEACAM6 Expression in COS-7 Cells
We next examined the effects of CEACAM6 expression on vimentin architecture in COS-7 cells. Endogenous vimentin in COS-7 cells showed filamentous structures developing around nuclei and in cell projections (Fig. 8A) . The full-length Ceacam6 coding region was amplified by RT-PCR and tagged with FLAG (FLAG-CEACAM6) in pFLAG-CMV-5.1 expression vector for transfection into COS-7 cells. FLAG-CEA-CAM6 expressed in COS-7 cells was detected predominantly in the perinuclear region as filamentous mesh (Fig. 8B) . Control samples stained with preimmune serum or nontransfected cells did not produce any immunosignal (Fig.  8C) . When transfected cells were examined after double immunostaining with anti-FLAG antibody and the antivimentin antibody, we noticed that FLAG-CEACAM6 protein expressed in COS-7 cells was found to be partially colocalized with vimentin (Fig. 8D) . In cells highly expressing FLAG-CEACAM6, vimentin colocalized with FLAG-CEACAM6 tended to aggregate around nuclei, no longer taking a filamentous form in the cytoplasm (Fig. 8E) .
To investigate which part of CEACAM6 protein is essential for association with vimentin in the transfected cells, we constructed pFLAG expression vectors encoding two types of CEACAM6 mutants fused with FLAG tags: FLAG-CEA-CAM6 (1-148) lacking C-terminal 118 amino acids and FLAG-CEACAM6 (145-266) lacking N-terminal 144 amino acids. Association and aggregations of vimentin with expressed CEACAM6 were observed in COS-7 cells expressing FLAG-CEACAM6 (1-148; Fig. 8F ) but not observed in the cells transfected with FLAG-CEACAM6 (145-266; Fig. 8G ).
To confirm the interaction between CEACAM6 and vimentin in transfected cell, COS-7 cells expressing FLAG-CEACAM6 were solubilized and processed for immunoprecipitation with the anti-FLAG antibody. Precipitated proteins were subjected to immunoblot analysis using either the anti-FLAG antibody (Fig. 9A) or the anti-vimentin antibody (Fig.  9B) . On the blot, the anti-FLAG antibody recognized FLAG-CEACAM6 proteins migrating at 40 kDa with minor bands at 38 kDa and 27 kDa (Fig. 9A) . Vimentin was detected in the immunoprecipitates but undetectable in the samples prepared from nontransfected control cells (Fig. 9B) , suggesting that CEACAM6 interacts with vimentin in transfected COS-7 cells.
DISCUSSION
Intermediate filaments serve as the mechanical resilient components and cytoskeletal scaffolds in the cytoplasm [17] [18] [19] . Vimentin, the major component of intermediate filament in mesenchyme-derived cells, acts as the modulator of signal transduction [20] . During mice development, vimentin is involved in motility of neural crest, parietal endoderm, and mesenchymal cells [21] [22] [23] . Vimentin-deficient mice showed reduction of renal mass [24] and impaired wound healing [25] . Primary fibroblasts derived from vimentin-deficient mice showed impairment of the mechanical stability, migration, and contractile capacity [26] . Whereas vimentin possess wideranging biological functions as described above, the regulation mechanisms of vimentin architecture in cells are poorly understood.
In Sertoli cells, the intermediate filament vimentin network encircles the nucleus, has peripheral extensions, and changes during spermatogenesis [20] . The collapse of vimentin filaments in Sertoli cells after xenobiotic treatment brought about the loss of structural integrity of the seminiferous epithelium with spermatogenic cell apoptosis [27, 28] . Di(nbutyl) phthalate induced collapse of vimentin filaments and subsequent apoptosis of germ cells due to the loss of the support and nurture provided by Sertoli cells [29] . These reports that collapse of vimentin has serious effects on the development of germ cells are not consistent with the fact that vimentin-deficient mice reproduce without an obvious phenotype [30] . More studies are needed to understand the role of vimentin in spermatogenesis.
Several proteins, such as filamin A [31] and plectin [32] , have been reported to be associated with vimentin. Filamin A (FLNA) is an actin cross-linking protein required for membrane stability, integrin-dependent mechanoprotection, adhesion, and motility [33] [34] [35] . Human melanoma lines lacking FLNA show impaired locomotion due to cytoskeletal defects [36] . Knockdown of FLNA in HEK-293 cells and 3T3 cells by small interfering RNA resulted in reduction of their cell adhesion and spreading [31] . Plectin, a vimentin-associated protein in Sertoli cell [37] , is a cross-linking protein that connects the intermediate filaments to the other cytoskeletal filaments. It also links vimentin filaments to the membraneassociated junctional sites. In rat Sertoli cells, plectin is not only concentrated at the perinuclear region but also located at the cell periphery where intermediate filaments associate with desmosome-like junctions or ectoplasmic specializations [37] . Plectin-null mice died within 2-3 days after birth, exhibiting blisters of the oral cavity and myopathies in skeletal muscle and abnormal cytoarchitecture in heart [38, 39] . Thus, vimentin-associated proteins serve significant roles in cytoarchitecture, cell stability, mechanoprotection, adhesion, motility, and spreading.
We have recently isolated CEACAM6 and its novel spliced variant CEACAM6-L from rat testis by differential display and cDNA cloning technique [10] . Ceacam6 encodes a protein with only one Ig-like domain, while Ceacam6-L encodes a protein with one Ig-like domain, three IgCAM domains, a transmembrane region, and a short intracellular region. We have proposed that CEACAM6-L, which is expressed in Sertoli cells, might work as a novel adhesion molecule at apical ectoplasmic specialization in the seminiferous epithelium.
In this study, we presented the data showing the expression and the localization of CEACAM6 in rat testis. Ceacam6 was expressed predominantly in rat testis, and its expression was developmentally up-regulated in testis. Immunoblot analysis and immunohistochemical data showed that CEACAM6 was expressed in Sertoli cells and interstitial cells of the rat testis as a vimentin-associated protein. The association between CEA-CAM6 and vimentin in Sertoli cells was observed throughout postnatal development of the seminiferous tubules. Thus, the localization of CEACAM6 in Sertoli cells is quite different from that of CEACAM6-L in spite of the fact that the two molecules are encoded in a single gene.
Endogenous vimentin in COS-7 cells developed around nuclei and extended toward the cell periphery as the filamentous structures. Transfection experiments followed by immunofluorescence microscopy showed that CEACAM6 expressed in COS-7 cells was located around nuclei and associated with endogenous vimentin. In addition, association of CEACAM6 with vimentin in rat testis and COS-7 cells was confirmed by immunoprecipitation assay. These data further support our data showing that CEACAM6 might be a novel vimentin-associated protein expressed in Sertoli cells.
Overexpression of CEACAM6 in COS-7 cells brought about aggregation of vimentin filaments around nuclei concomitant with the loss of vimentin filaments in the cell periphery. We revealed that CEACAM6 lacking C-terminal 118 amino acids induced vimentin aggregation, whereas CEACAM6 lacking N-terminal 144 amino acids failed to induce vimentin aggregation. These results suggest that the Nterminal region of CEACAM6, including an Ig-like domain, seems to be necessary for both association with vimentin and its aggregation. These data prompt us to hypothesize that CEACAM6 might be involved in regulation of vimentin architecture mainly via its N-terminal Ig-like domain.
Immunoprecipitation analysis showed that FLAG-CEA-CAM6 expressed in COS-7 cells was divided into three types of proteins in terms of their size. There is a possibility that the apparent difference of molecular weight might be due to posttranslational modifications of CEACAM6 protein. Since human CEACAM6 as well as many cytoplasmic proteins, including cytoskeletal proteins, has been reported to be glycosylated [40, 41] , we examined the glycosylated condition of CEACAM6 by alkaline-induced b-elimination that is used to liberate O-linked glycans from glycosylated protein [42] . However, the molecular weight of CEACAM6-FLAG proteins has not been changed by the method so far. It remains to be determined what mechanism affects the molecular weight of CEACAM6 proteins.
In conclusion, Ceacam6 dominantly expressed in rat testis encodes a protein colocalized with vimentin in rat Sertoli cells. CEACAM6 might be involved in regulation of vimentin architecture in the cells. Further studies of CEACAM6 may cast a new light on the mechanisms by which Sertoli cells change their cell morphology through the seminiferous tubule cycle.
